EyePoint Pharmaceuticals
EYPT
#6953
Rank
A$0.68 B
Marketcap
$9.96
Share price
-2.60%
Change (1 day)
-60.71%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2024 (TTM): -A$0.2 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are A$43.27 Million. a decrease over its 2023 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.21 Billion88.25%
2023 -A$0.11 Billion-29.88%
2022 -A$0.16 Billion87.2%
2021 -A$82.75 Million38.58%
2020 -A$59.71 Million-24.56%
2019 -A$79.15 Million
2017 -A$36.1 Million22.59%
2016 -A$29.45 Million-8.02%
2015 -A$32.02 Million-296.09%
2014 A$16.32 M-174.02%
2013 -A$22.06 Million37.42%
2012 -A$16.05 Million-56.29%
2011 -A$36.72 Million-1062.38%
2010 A$3.81 M-250.43%
2009 -A$2.54 Million-89.5%
2008 -A$24.16 Million
2005 -A$14.9 Million56.99%
2004 -A$9.5 Million73.7%
2003 -A$5.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$55.16 M-126.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$3.38 Million-98.35% Bahamas